PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8523379-7	1995	Quinapril also caused a reduction from 144 +/- 10/94 +/- 7 to 134 +/- 12/88 +/- 8 mm Hg (P < 0.001 for both SBP and DBP).	Quinapril	0-9	D-box binding PAR bZIP transcription factor	Homo sapiens	119-122	
7807504-3	1994	In study I, 88 patients were randomised to receive quinapril (10-40 mg twice daily) which was titrated upwards every one to two weeks as necessary to reduce DBP < or = 90 mmHg (titration period six weeks, followed by an additional six weeks of therapy during which open-labelled beta-blocker therapy could be added for nonresponders).	Quinapril	51-60	D-box binding PAR bZIP transcription factor	Homo sapiens	157-160	
7807504-4	1994	In study II, 84 patients were randomised to receive quinapril (5-20 mg twice daily) which was titrated upwards every four weeks as necessary to reduce DBP < or = 90 mmHg (titration period 16 weeks, followed by a 12-week maintenance period).	Quinapril	52-61	D-box binding PAR bZIP transcription factor	Homo sapiens	151-154	
7918140-5	1994	Open-label quinapril treatment resulted in significant decreases in mean systolic (SBP) and diastolic (DBP) blood pressure.	Quinapril	11-20	D-box binding PAR bZIP transcription factor	Homo sapiens	103-106